Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current treatment strategy. Freeman SA, Zephir H. Rev Neurol (Paris) 2024 Apr 9:S0035-3787(24)00474.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Freeman SA, Zephir H. Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current treatment strategy. Rev Neurol (Paris) 2024 Apr 9:S0035-3787(24)00474.
PMID: 38599976